CD276 and central nervous system neoplasm: Many trials investigating CAR-T for ST and CNS tumors focused on cell surface antigens that are expressed at high levels on malignant cells but scarcely discovered in normal tissues, including B7-H3/CD276 and GD2 [10,27-31].